Guest guest Posted December 31, 2009 Report Share Posted December 31, 2009 Must be waiting for more bribe money Sheri Pfizer says FDA is still reviewing Prevnar 13 NEW YORK Pfizer Inc. says the Food and Drug Administration is again extending its review of Prevnar 13, a children’s pneumococcal vaccine. The FDA’s decision was due Wednesday, but Pfizer says the agency has not completed its review. It did not say when the process might be complete. The FDA was originally scheduled to make a decision by Sept. 30, but decided to extend that review by three months. Prevnar 13 is intended to reduce the risk of infection by 13 types of pneumococcal disease, which can cause ear infections, meningitis, pneumonia and blood infections. It is a newer version of a vaccine that has been on the market for nine years, and considered one of the most important products Pfizer acquired when it bought rival Wyeth for $68 billion this year. Sheri Nakken, R.N., MA, Hahnemannian Homeopath Vaccination Information & Choice Network, Washington State, USA Vaccines - http://vaccinationdangers.wordpress.com/ Vaccine Dangers, Childhood Disease Classes & Homeopathy Online/email courses - next classes start January 6 & 7 http://www.wellwithin1.com/vaccineclass.htm or http://www.wellwithin1.com/homeo.htm Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.